All very good points. I think there is legitimacy and then there is non-legitimacy. I'm confident in my opinion but I appreciate that it differs from yours.
Mesoblast has a 8 of clubs. Cynata has a ace of diamonds.
Clubs are trumps. No inference to the Orange one.
Cynata should issue a statement on intended progress with GVHD. If they spell out the reasons and show feasibility it could be only good for Cynata. I suggest it might be time for reflection given what has happened. A statement would clear it all up. It is the only trial Cynata is paying for and the only FDA trial.
Cynata through Ross mainly has marketed themselves as a better Mesoblast over and over for years. Do you recall the coffee analogy. Yeah, nor do I - I do remember there was one that sort of made logical sense. Ha ha ha.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 352684 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 54843 | 3 |
View Market Depth
| Last trade - 10.11am 17/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable